From Medscape Oncology

Coverage from the

Transplantation & Cellular Therapy (TCT) 2021 Annual Meeting

Joint meeting of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR)

February 08 - 12, 2021; Virtual Meeting

February 08 - 12, 2021 Virtual Meeting

Conference News

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from TCT 2020

  • Cord Blood Instead of Bone Marrow for HSCT for Blood Cancers Cord Blood Instead of Bone Marrow for HSCT for Blood Cancers Clinicians should get over their preconceptions about sourcing stem cells from cord blood for transplants in hematologic malignancies, as it can achieve good short- and long-term outcomes, says an expert in the field.
  • Caution: Higher Radiation Dose Linked to Worse NHL Outcomes Caution: Higher Radiation Dose Linked to Worse NHL Outcomes Among patients with non-Hodgkin lymphoma who underwent reduced-intensity conditioning for stem cell transplant, overall survival was lower if they received a higher dose of radiation.
  • Hidden Costs of CAR T-Cell Therapy Hidden Costs of CAR T-Cell Therapy Patients are on the hook for many expenses that are usually not covered by insurance, which add to financial hardships.
  • Geriatric Assessment Before HSCT Supports Good Outcomes Geriatric Assessment Before HSCT Supports Good Outcomes Survival outcomes support the benefits of a geriatric assessment for patients age 70 and older with blood cancers who are candidates for hematopoietic stem cell transplants (HSCT).

Previous Coverage